Paperplane Therapeutics
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $1.5M
Investors
- 6
About Paperplane Therapeutics
Founded in 2019 by CEO Jean-Simon Fortin and CTO David Paquin, Paperplane Therapeutics develops virtual reality solutions to alleviate pain and anxiety in medical environments, enhancing patient experiences through immersive technology. Paperplane Therapeutics focuses on VR therapeutic solutions that aid pain management and anxiety reduction in healthcare settings. Paperplane Therapeutics specializes in virtual reality (VR) therapeutic solutions designed to manage pain and anxiety in healthcare settings. Their primary offerings include immersive, interactive VR experiences that divert patients' attention during medical procedures, thus minimizing the need for pharmacological interventions such as sedation or general anesthesia. These solutions are particularly beneficial in pediatrics, dentistry, and other areas requiring patient cooperation, such as orthopedics and burn care. The company collaborates with healthcare providers and institutions, including notable partnerships with the Mayo Clinic and CHU Sainte-Justine, to conduct clinical trials and validate the efficacy of their products. Currently, their services are available in North America, with expansions aimed at broader global markets. The revenue model for Paperplane Therapeutics is structured around B2B partnerships with healthcare facilities and practitioners who integrate their VR therapies into clinical practice. Revenue is generated through subscription-based access to their platform, which allows hospitals and clinics to utilize their immersive VR technologies across various departments. Additionally, the company engages in direct transactions with dental professionals who implement their technology to enhance patient experiences during procedures. These transactions are facilitated through contracts that specify pricing and usage terms for their VR therapeutic solutions, which are engineered to enhance patient care and improve clinical outcomes. Future product launches are being designed to further enhance the therapeutic applications of their VR solutions, while specific strategies for entering European markets are currently in development.
Who invested in Paperplane Therapeutics
6 investors across 1 round
See all investors in Paperplane Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 10, 2025
Amount
$1.5M
Investors
Questions about Paperplane Therapeutics
Who invested in Paperplane Therapeutics?
Paperplane Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Paperplane Therapeutics raised?
Paperplane Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Paperplane Therapeutics last raise money?
Paperplane Therapeutics's most recent round on record is a Seed, in Feb 2025.
What does Paperplane Therapeutics do?
Founded in 2019 by CEO Jean-Simon Fortin and CTO David Paquin, Paperplane Therapeutics develops virtual reality solutions to alleviate pain and anxiety in medical environments, enhancing patient experiences through immersive technology.
Where is Paperplane Therapeutics headquartered?
Paperplane Therapeutics is headquartered in Granby, Canada.
Which VCs invest in companies like Paperplane Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Paperplane Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Paperplane Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.